Kezar Life Sciences Inc (NAS:KZR)
$ 0.7615 -0.0065 (-0.85%) Market Cap: 55.44 Mil Enterprise Value: -105.95 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 28/100

Kezar Life Sciences Inc at Wells Fargo Healthcare Conference Transcript

Sep 07, 2023 / 04:45PM GMT
Release Date Price: $1.32 (-7.69%)
Derek Archila
Wells Fargo - Analyst

All right. Thank you. I think we'll get started here with the afternoon session at the Wells Fargo Healthcare Conference. My name is Derek Archila. I'm one of the biotech analysts here at Wells. Very excited to have our next fireside discussion with Kezar Life Sciences. So from the company, we have Noreen Henig. She is the Chief Medical Officer of the company. So Noreen, thanks for joining us.

Noreen Henig
Kezar Life Sciences, Inc. - Chief Medical Officer

Thank you for having me.

Derek Archila
Wells Fargo - Analyst

Awesome. Maybe just to start off, give us a little bit of background about Kezar and then maybe kind of, again, state of the business right now in terms of like where you are, what you're working on, and then we can dig into some of the questions here.

Noreen Henig
Kezar Life Sciences, Inc. - Chief Medical Officer

Sure. So Kezar Life Sciences is a biotech. We're headquartered in the San Francisco Bay area. We're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot